Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
LEQEMBI® Scheduled for Launch in Japan for Alzheimer's Disease Treatment on December 20th
Wednesday, December 13, 2023Eisai the collaborator of BioArctic AB has announced the forthcoming launch of LEQEMBI in Japan on December This follows its inclusion in the price listing on the Japan
NMPA Approves New Drug Application for Henlius Anti-PD-1 mAb Serplulimab Combined with Chemotherapy in First-Line non-squamous NSCLC Treatment
Wednesday, December 13, 2023Shanghai Henlius Biotech Inc has recently disclosed that the National Medical Products Administration has accepted the New Drug Application for a new indication of HANSIZHUANG
Rafarma Pharmaceutical Discloses Recent Partnerships With Kelun Lifesciences (Pvt) Ltd in Sri Lanka and El Salvador University
Tuesday, December 12, 2023Rafarma Pharmaceuticals is excited to announce a preliminary agreement with Kelun Lifesciences Pvt Ltd a pharmaceutical company based in Sri Lanka signed
Mabwell's Nectin-4 ADC Approved for Phase III Trial by CDE
Tuesday, December 12, 2023Mabwell an innovative biopharmaceutical company with a comprehensive industry chain has obtained approval from the Center for Drug Evaluation of the National Medical Products Administration for its submission This submission pertains
NMPA Grants Approval for Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma, as Announced by CStone
Monday, December 11, 2023CStone Pharmaceuticals a prominent biopharmaceutical company specializing in innovative immunooncology therapies has received approval from the National Medical Products Administration
Rigel Pharmaceuticals and MD Anderson Establish Strategic Collaboration to Progress REZLIDHIA® (Olutasidenib) in AML and Other Cancer Forms
Saturday, December 09, 2023Rigel Pharmaceuticals Inc and The University of Texas MD Anderson Cancer Center have recently revealed a strategic development collaboration spanning multiple years to extend the assessment of REZLIDHIA
Innovent Biologics and Synaffix Broaden ADC Collaboration After Positive Initial Clinical Signals From Ongoing Phase 1 Study
Friday, December 08, 2023Innovent Biologics Inc a prominent biopharmaceutical company specializing in the development manufacturing and commercialization of highquality medicines for various medical conditions
FDA Approves Avzivi® (bevacizumab-tnjn), a Biosimilar Referencing Avastin®, Developed by Bio-Thera Solutions
Friday, December 08, 2023BioThera Solutions Ltd has announced that the United States Food and Drug Administration has given the green light for Avzivi bevacizumabtnjn a biosimilar referencing Avastin
Abelzeta Pharma and Astrazeneca Announce Collaboration for the Joint Development of an Original Glypican 3 (GPC3) Armored CAR-T Therapy in China
Friday, December 08, 2023AbelZeta Pharma Inc a global clinicalstage biopharmaceutical company specializing in innovative cell therapies for cancer inflammatory and immunological diseases has recently announced a partnership with AstraZeneca
Antengene Receives Regulatory Approval in Macau for XPOVIO® in the Treatment of Relapsed and/or Refractory Multiple Myeloma
Thursday, December 07, 2023Antengene Corporation Limited listed as SEHK HK a renowned global biopharmaceutical company specializing in innovative therapies for hematology and oncology has obtained approval from the Pharmaceutical
